Targets for Pharmacological Modulation of Cardiac Fibrosis
- 1 January 2005
- book chapter
- Published by Springer Nature
- p. 275-310
- https://doi.org/10.1007/0-387-22825-x_14
Abstract
No abstract availableKeywords
This publication has 180 references indexed in Scilit:
- Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2002
- Effect of Ramipril and Furosemide Treatment on Interstitial Remodeling in Post-Infarction Heart Failure Rat HeartsJournal of Molecular and Cellular Cardiology, 2002
- Extracellular Matrix Proteins in Cardiac Fibroblasts Derived from Rat Hearts with Chronic Pressure Overload: Effects of Beta-receptor BlockadeJournal of Molecular and Cellular Cardiology, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Novel Inhibitors of Advanced Glycation EndproductsBiochemical and Biophysical Research Communications, 1999
- Control of Nitric Oxide Production by Transforming Growth Factor-β1: Mechanistic Insights and Potential Relevance to Human DiseaseNitric Oxide, 1997
- Chronic Aspirin Treatment Affects Collagen Deposition in Non-infarcted Myocardium During Remodeling after Coronary Artery Ligation in the RatJournal of Molecular and Cellular Cardiology, 1995
- Prolyl hydroxylation regulates intracellular procollagen degradation in cultured rat cardiac fibroblastsJournal of Molecular and Cellular Cardiology, 1995
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Inhibitors of procollagen N-protease. Synthetic peptides with sequences similar to the cleavage site in the pro.alpha.1 (I) chainBiochemistry, 1980